PROSPECTIVE STUDY OF CELLULAR IMMUNITY TO HEPATITIS-B-VIRUS ANTIGENS FROM THE EARLY INCUBATION PHASE OF ACUTE HEPATITIS B

Sandro Vento, Sergio Ranieri, Roger Williams, Elio G. Rondanelli, Charles J. O'Brien, Adrian L.W.F. Eddleston

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Cellular immunity to hepatitis-B-virus (HBV) antigens was followed prospectively in five patients who were identified in the early incubation phase of acute HBV infection, between 30 and 70 days before the onset of liver damage. Cellular immunity to pre-S antigens was the first detectable immune response, appearing 30 days before the first rise in serum aminotransferases in every case. T-cell sensitisation to HBcAg followed, with IgM anti-HBc appearing 10 days later. A cellular immune response to HBsAg was the last to appear, 10 days before the onset of liver damage. These cellular immune responses are the earliest host responses to the virus infection and could be critical in initiating and directing the processes of liver damage and viral clearance.

Original languageEnglish
Pages (from-to)119-122
Number of pages4
JournalThe Lancet
Volume330
Issue number8551
DOIs
Publication statusPublished - Jul 18 1987

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'PROSPECTIVE STUDY OF CELLULAR IMMUNITY TO HEPATITIS-B-VIRUS ANTIGENS FROM THE EARLY INCUBATION PHASE OF ACUTE HEPATITIS B'. Together they form a unique fingerprint.

  • Cite this

    Vento, S., Ranieri, S., Williams, R., Rondanelli, E. G., O'Brien, C. J., & Eddleston, A. L. W. F. (1987). PROSPECTIVE STUDY OF CELLULAR IMMUNITY TO HEPATITIS-B-VIRUS ANTIGENS FROM THE EARLY INCUBATION PHASE OF ACUTE HEPATITIS B. The Lancet, 330(8551), 119-122. https://doi.org/10.1016/S0140-6736(87)92329-4